Overview
Didier Serteyn is chief executive of Revatis, based in Liège. He joined Revatis as chief scientific officer in 2014, a role he continues to hold, and became managing director in 2018. Since 2007 he has also been chief scientific officer of Bioptis, and since 2000 a managing partner of the Mont-le-Soie, Equine Research Center.
From October 1995 to October 2024 he was a professor at the University of Liège, holding the qualifications DVM, PhD, Dipl ECVAA and Dipl ECVSMR. He studied veterinary medicine at the University of Liège, completing his degree in 1982.
His stated areas of expertise are creativity and innovation, stem cells, exosomes, regenerative medicine, and research and development.
Career history
In the news
- A nice opportunity to learn a little bit more about this fascinating project.
- I really enjoyed attending the World Mitochondria Society Congress 2026 in Berlin and exchanging ideas with researchers sharing a common interest in mitochondria and their role in medicine. I was particularly impressed by the recent advances in mitochondrial transfer between cells, a fascinating field with exciting therapeutic perspectives. It also reinforced my conviction that Revatis’ two patented technology platforms, based on muscle-derived MSCs and their secretome, have much to contribute in this area. A special thanks to
- We are convinced that Stem cells can improve a lot of ophthalmologic diseases. We are finalizing a clinical trial in horses affected by immune mediated keratitis with very promising results. #regenerativemedicine #ophtalmology #horse #stemcells
- More and more clinical trials using stem cells👍. It remains a fascinating domain with huge potential in many conditions. We uses IA injection for equine laminitis with amazing results in partnership with Queensland University. #stemcells #osteoarthritis #regenerativemedicine #horse
- Proud to participate to this amazing congress. Congratulations to the organizing and scientific committee.
- Objective assessment of equine lameness is essential for evaluating the effectiveness of innovative treatments
- A great event to support the R&D community working on this important disease. Join us💪
- Equestrian industry is a main economic force in Belgium and Europe. Many thanks to Equisfair to participate and represent all off us !
This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.